The no-flow phenomenon following drug-coated balloon angioplasty in a patient with chronic limb-threatening ischemia and a history of below-knee amputation.

Mituso Sobajima, Teruhiko Imamura, Atsuko Fukuo, Yohei Ueno, Hiroshi Onoda, Hiroshi Ueno, Koichiro Kinugawa

Abstract readCase Reports

In one paragraph

Article in Journal of cardiology cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mituso SobajimaThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Teruhiko ImamuraThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Atsuko FukuoThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Yohei UenoThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Hiroshi OnodaThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Hiroshi UenoThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Koichiro KinugawaThe Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endovascular treatment using a drug-coated balloon (DCB) reduces restenosis and target vessel re-vascularization rate in patients with peripheral artery disease such as claudication and chronic limb-threatening ischemia (CLTI). However, its safety and efficacy in patients with post-below-knee amputation remain unknown. We had a patient with CLTI and a history of below-knee amputation, who suffered a no-flow phenomenon following DCB angioplasty that required above-knee amputation. DCB angioplasty might not be appropriate for those with severe CLTI and histories of amputation. Learning objective: The present report describes the risk of endovascular treatment using a drug-coated balloon for chronic limb-threatening ischemia patients with a below-knee amputated limb.

Indexed as

Chronic limb-threatening ischemiaDownstream effectDrug-coated balloonEndovascular treatmentNo-flow phenomenon

Identifiers

PMID36910034

DOI10.1016/j.jccase.2022.12.002

PMCPMC9995684

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.